Publication | Closed Access
Dapagliflozin suppresses ER stress and protects doxorubicin-induced cardiotoxicity in breast cancer patients
75
Citations
14
References
2020
Year
InflammationDoxorubicin-induced CardiotoxicityBreast OncologyOncologyBreast Cancer PatientsMedicineCardiovascular PharmacologyBreast CancerPharmacotherapyEr StressAnti-cancer AgentCardiovascular ToxicityPharmacologyOxidative Stress
| Year | Citations | |
|---|---|---|
Page 1
Page 1